Mary Beth Terry

Mary Beth Terry

Mary Beth Terry

Epidemiology (In Environmental Health Sciences)


722 West 168th Street, Room 1611
New York 10032
Email: CV:


Mary Beth Terry, PhD, focuses her research on breast cancer and in the molecular epidemiology and lifecourse methods of the disease, in particular. She is a cancer epidemiologist with over 16 years of leading studies of breast cancer etiology specifically focused on the role of genetics, epigenetics, and other biomarkers play in modifying the effects of environmental exposures. Dr. Terry currently leads NIH grants funded through the National Cancer Institute and the National Institute for Environmental Health Sciences that focus on following cancer risk within family-based cohorts focused on studying environmental exposures during key windows of breast susceptibility. She is also leading prospective studies to validate and extend breast cancer risk assessment models. She is also funded through the Breast Cancer Research Foundation. Dr. Terry has authored or co-authored over 250 scientific publications. Her more recent work supports that environmental exposures and biomarkers are associated with modifying risk even within high risk families. Understanding whether biomarkers can help explain risk in higher risk women is important as only a minority of women with a family history of cancer carry the BRCA1 or BRCA2 mutation. Her work also focuses on measuring risk factors for mammographic density, a strong intermediate marker of breast cancer. In addition to her doctorate in epidemiology, Dr. Terry has a Master's degree in economics and previously worked as an econometrician and program evaluator for a number of government-sponsored programs. Dr. Terry teaches introductory and advanced epidemiologic methods.



PhD, 1999, Columbia University
MA, 1990, University of Washington
BA, 1988, George Washington University

Editorial Boards

International Journal of Epidemiology

Columbia Affiliations

Co-Leader Cancer Epidemiology, Herbert Irving Cancer Center

Other Affiliations

Society for Epidemiologic Research
American Association for Cancer Research
American Society for Preventive Oncology

Honors & Awards

Dean's Excellence in Mentoring Award 2013
CUMC Garvey Academy

Areas of Expertise

Longitudinal Studies, Research Design and Methods, Cancer, Cancer Breast, Cancer Screening, Genetic Susceptibility, Genetics

Select Urban Health Activities

Early Life Factors. Adolescent growth and Breast Cancer Susceptiblity: Currently following three separate community cohorts (two birth cohorts, one pubertal cohort) to examine early life and adolescent exposures and breast cancer susceptibility.
Breast Cancer in High Risk Families: Currently following up a long term cohort of high risk families recruited in New York city to understand genetic, environmental, and epigenetic influences in breast cancer risk.
Mammographic Density in an Urban Cohort: This study is focused on women in Brooklyn New York to understand differences in mammographic density among racial and ethnic subgroups.

Select Global Activities

BCFR: Breast Cancer Family Registry
International Breast Cancer Network: International BRCA1 and BRCA2 prospect cohort
International Breast Cancer Network: Network of countries from six continents focused on modifiable factors and cancer risk

Select Publications

Shen J, Liao Y, Hopper JL, Goldberg M, Santella RM, Terry MB.Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer.Br J Cancer. 2017 Mar 28. doi: 10.1038/bjc.2017.81
Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, Goldgar DE, Knight JA, Whittemore AS, Chung WK, Apicella C, Hopper JL. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC).Int J Epidemiol. 2016 Jun;45(3):683-92. doi: 10.1093/ije/dyv118. Epub 2015 Jul 13.
Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB.Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst. 2015 May 8;107(7). pii: djv124. doi: 10.1093/jnci/djv124. Print 2015 Jul.
Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB. Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer. 2014 Feb 18. doi: 10.1038/bjc.2013.807. [Epub ahead of print] PMID: 24548865
Flom JD, Ferris JS, Liao Y, Tehranifar P, Belessiotis Richards C, Cho YH, Gonzalez K, Santella RM, Terry MB. Prenatal Smoke Exposure and Genomic DNA Methylation in a Multi-ethnic Urban Birth Cohort. Cancer Epidemiol Biomarkers Prev. 2011 Oct 12. [Epub ahead of print] PMID: 21994404.
Terry MB, Ferris JS, Tehranifar P, Wei Y, Flom JD. Birth weight, postnatal growth, and age at menarche. Am J Epidemiol. 170(1) 72-9 2009
Terry MB, Buist DS, Trentham-Dietz A, James-Todd TM, Liao Y. Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women. Cancer Epidemiol Biomarkers Prev. 17(5) 1088-95 2008
Terry MB, Wei Y, Esserman D. Maternal, Birth, and Early-Life Influences on Adult Body Size in Women. Am J Epidemiol. 2007; 166(1): 5-13.
Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 2433-40 2004
Terry MB, Neugut AI, Schwartz S, Susser E Risk factors for a causal intermediate and an endpoint: reconciling differences Am J Epidemiol 151 339-45 2000

See a complete list of publicationsBack to Top